[Hansenula anomala fungemia]. 2003

S C Mestroni, and A J Bava
Laboratorio de Micología, Hospital Interzonal General de Agudos (HIGA) San Martín, Cátedra de Micología y Parasitología, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina. nemes@netverk.com.ar

We communicate 5 episodes of fungemia produced by Hansenula anomala (Candida pelliculosa) in 4 adult patients and 1 preterm newborn admitted in different wards of the HIGA San Martín of La Plata City during a 13 month period. The isolates were achieved by culture of blood obtained by venipuncture (5/5) and from catheter (2/5) and were processed with BacTAlert system and lysis-centrifugation method. API 32 C system achieved the identification of the isolated yeasts. Among the patients, treatments with antibiotics (5/5) and corticoids (2/5), catheters (3/5), previous surgical procedures and surgical wounds (2/5), prematurely (1/5) and neutropenia (1/5) were present as predisposing factors of fungemia. Three out of the 5 episodes evolved favorably and the remaining 2 patients died in spite of the antifungal treatment. The diagnosis of 4 out of 5 cases in a brief lapse (3 months), and 2 simultaneously in 2 different wards, as well as the lack of other isolates of H. anomala in our Hospital, before and after of the studied period, suggests the possibility of an outbreak. We claim that H. anomala is an emergent fungal pathogen that must be taken into account as etiological agent of fungemia, fundamentally in patients with different predisposing factors.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D010843 Pichia Yeast-like ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES isolated from exuded tree sap. Hansenula,Hansenulas,Pichias
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection

Related Publications

S C Mestroni, and A J Bava
January 1988, Reviews of infectious diseases,
S C Mestroni, and A J Bava
October 1986, New York state journal of medicine,
S C Mestroni, and A J Bava
March 1989, Archives of internal medicine,
S C Mestroni, and A J Bava
May 1992, Internal medicine (Tokyo, Japan),
S C Mestroni, and A J Bava
December 2000, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
S C Mestroni, and A J Bava
February 1996, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
S C Mestroni, and A J Bava
January 1989, Reviews of infectious diseases,
S C Mestroni, and A J Bava
February 1996, Journal of chemotherapy (Florence, Italy),
Copied contents to your clipboard!